, Volume 62, Issue 8, pp 1357–1365 | Cite as

Concordance of glycaemic and cardiometabolic traits between Indian women with history of gestational diabetes mellitus and their spouses: an opportunity to target the household

  • Alpesh Goyal
  • Yashdeep GuptaEmail author
  • Mani Kalaivani
  • M. Jeeva Sankar
  • Garima Kachhawa
  • Neerja Bhatla
  • Nandita Gupta
  • Nikhil Tandon



The aim of this study was to investigate the concordance of dysglycaemia (prediabetes or diabetes) and cardiometabolic traits between women with a history of gestational diabetes mellitus (GDM) and their spouses.


Using hospital medical records, women with GDM (diagnosed between 2012 and 2016) and their spouses were invited to participate in the study and to attend a scheduled hospital visit in a fasting state. Sociodemographic, anthropometric and medical data were collected, and a 75 g OGTT with serum insulin estimation, HbA1c measurement and fasting lipid profile were performed at the visit. Prediabetes and diabetes were defined using ADA criteria and the metabolic syndrome was defined using IDF criteria.


A total of 214 couples participated in the study. Women were tested at a mean ± SD age of 32.4 ± 4.6 years and median (quartile [q]25–q75) of 19.5 (11–44) months following the index delivery, while men were tested at a mean ± SD age of 36.4 ± 5.4 years. A total of 72 (33.6%) couples showed concordance for dysglycaemia, while 99 (46.3%) and 51 (23.8%) couples were concordant for overweight/obesity and the metabolic syndrome, respectively. A total of 146 (68.2%) couples showed concordance for any of the above three factors. The presence of dysglycaemia in one partner was associated with an increased risk of dysglycaemia in the other partner (OR 1.80 [95% CI 1.04, 3.11]). Similarly, being overweight/obese (OR 2.19 [95% CI 1.22, 3.93]) and presence of the metabolic syndrome (OR 2.01 [95% CI 1.16, 3.50]) in one partner was associated with an increased risk of these conditions in the other partner. Both women and men were more likely to have dysglycaemia if they had a partner with dysglycaemia. Women with a partner with dysglycaemia had a significantly higher BMI, waist circumference and diastolic BP, and a significantly higher probability of low HDL-cholesterol (<1.29 mmol/l) and the metabolic syndrome compared with women with a normoglycaemic partner. No such differences were observed for men with or without a partner with dysglycaemia.


The high degree of spousal concordance found in this study suggests social clustering of glycaemic and cardiometabolic traits among biologically unrelated individuals. This provides us with an opportunity to target the behavioural interventions at the level of the ‘married couple’, which may be a novel and cost-effective method of combating the current diabetes epidemic.


Cardiometabolic traits Dysglycaemia Gestational diabetes mellitus India South Asian Spousal concordance Spouse Type 2 diabetes 



Gestational diabetes mellitus


International Association of Diabetes and Pregnancy Study Groups



The authors are grateful to the study participants for generously donating their time and information. The authors would like to thank Y. Singh (Department of Endocrinology & Metabolism, All India Institute of Medical Sciences, New Delhi, India) for technical assistance in conducting the study.

Contribution statement

AG, YG and NT conceptualised the research, and were involved in study execution, data interpretation, manuscript preparation and revision. MK contributed to the study design, data interpretation and manuscript revision, and was responsible for the statistical analysis. NG supervised the laboratory work of this research and helped in the study design, data interpretation, manuscript preparation and revision. MJS, GK and NB contributed to the study execution, data interpretation, manuscript preparation and revision. All authors approved the final version of the manuscript. YG is the guarantor of this work.


This work was supported by a trainee grant from the Endocrine Society of India. The society and its members were not involved in any other aspect related to this manuscript.

Duality of interest

The authors declare that there is no duality of interest associated with this manuscript.

Supplementary material

125_2019_4903_MOESM1_ESM.pdf (21 kb)
ESM 1 (PDF 21 kb)


  1. 1.
    International Diabetes Federation (2017) IDF diabetes atlas, 8th edition. Available from Accessed 15 Oct 2018
  2. 2.
    Song C, Lyu Y, Li C et al (2018) Long-term risk of diabetes in women at varying durations after gestational diabetes: a systematic review and meta-analysis with more than 2 million women. Obes Rev 19(3):421–429. CrossRefPubMedGoogle Scholar
  3. 3.
    Mukerji G, Chiu M, Shah BR (2012) Impact of gestational diabetes on the risk of diabetes following pregnancy among Chinese and South Asian women. Diabetologia 55(8):2148–2153. CrossRefPubMedGoogle Scholar
  4. 4.
    Kale SD, Yajnik CS, Kulkarni SR et al (2004) High risk of diabetes and metabolic syndrome in Indian women with gestational diabetes mellitus. Diabet Med 21(11):1257–1258. CrossRefPubMedGoogle Scholar
  5. 5.
    Krishnaveni GV, Hill JC, Veena SR et al (2007) Gestational diabetes and the incidence of diabetes in the 5 years following the index pregnancy in South Indian women. Diabetes Res Clin Pract 78(3):398–404. CrossRefPubMedGoogle Scholar
  6. 6.
    Mahalakshmi MM, Bhavadharini B, Kumar M et al (2014) Clinical profile, outcomes, and progression to type 2 diabetes among Indian women with gestational diabetes mellitus seen at a diabetes center in south India. Indian J Endocrinol Metabol 18(3):400–406Google Scholar
  7. 7.
    Gupta Y, Kapoor D, Desai A et al (2017) Conversion of gestational diabetes mellitus to future type 2 diabetes mellitus and the predictive value of HbA1c in an Indian cohort. Diabet Med 34(1):37–43. CrossRefPubMedGoogle Scholar
  8. 8.
    Goyal A, Gupta Y, Kalaivani M et al (2018) Long term (>1 year) postpartum glucose tolerance status among Indian women with history of gestational diabetes mellitus (GDM) diagnosed by IADPSG criteria. Diabetes Res Clin Pract 142:154–161. CrossRefPubMedGoogle Scholar
  9. 9.
    Ratner RE (2007) Prevention of type 2 diabetes in women with previous gestational diabetes. Diabetes Care 30(Suppl 2):S242–S245. CrossRefPubMedGoogle Scholar
  10. 10.
    Clark HD, van Walraven C, Code C, Karovitch A, Keely E (2003) Did publication of a clinical practice guideline recommendation to screen for type 2 diabetes in women with gestational diabetes change practice? Diabetes Care 26(2):265–268. CrossRefPubMedGoogle Scholar
  11. 11.
    Dietz PM, Vesco KK, Callaghan WM et al (2008) Postpartum screening for diabetes after a gestational diabetes mellitus-affected pregnancy. Obstet Gynecol 112(4):868–874. CrossRefPubMedGoogle Scholar
  12. 12.
    Morrison MK, Collins CE, Lowe JM (2009) Postnatal testing for diabetes in Australian women following gestational diabetes mellitus. Aust N Z J Obstet Gynaecol 49(5):494–498. CrossRefPubMedGoogle Scholar
  13. 13.
    Pridjian G, Benjamin TD (2010) Update on gestational diabetes. Obstet Gynecol Clin N Am 37(2):255–267. CrossRefGoogle Scholar
  14. 14.
    Dasgupta K, Da Costa D, Pillay S et al (2013) Strategies to optimize participation in diabetes prevention programs following gestational diabetes: a focus group study. PLoS One 8(7):e67878. CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Dasgupta K, Ross N, Meltzer S et al (2015) Gestational diabetes mellitus in mothers as a diabetes predictor in fathers: a retrospective cohort analysis. Diabetes Care 38(9):e130–e131. CrossRefPubMedGoogle Scholar
  16. 16.
    Kragelund Nielsen K, Groth Grunnet L, Terkildsen Maindal H, Danish Diabetes Academy Workshop and Workshop Speakers (2018) Prevention of type 2 diabetes after gestational diabetes directed at the family context: a narrative review from the Danish Diabetes Academy symposium. Diabet Med 35(6):714–720. CrossRefPubMedGoogle Scholar
  17. 17.
    American Diabetes Association (2019) Standards of medical care in diabetes. Diabetes Care 42(Suppl 1):S1–S204Google Scholar
  18. 18.
    International Diabetes Federation (2006) The IDF consensus worldwide definition of the metabolic syndrome. Available from Accessed 11 Apr 2019
  19. 19.
    World Health Organisation (2018) Overweight and obesity. Available from: Accessed 11 Apr 2019
  20. 20.
    WHO Expert Consultation (2004) Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363(9403):157–163Google Scholar
  21. 21.
    Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28(7):412–419. CrossRefGoogle Scholar
  22. 22.
    Phillips DI, Clark PM, Hales CN, Osmond C (1994) Understanding oral glucose tolerance: comparison of glucose or insulin measurements during the oral glucose tolerance test with specific measurements of insulin resistance and secretion. Diabet Med 11(3):286–292. CrossRefPubMedGoogle Scholar
  23. 23.
    Utzschneider KM, Prigeon RL, Faulenbach MV et al (2009) Oral disposition index predicts the development of future diabetes above and beyond fasting and 2-h glucose levels. Diabetes Care 32(2):335–341. CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Faulenbach MV, Wright LA, Lorenzo C et al (2013) Impact of differences in glucose tolerance on the prevalence of a negative insulinogenic index. J Diabetes Complicat 27(2):158–161. CrossRefPubMedGoogle Scholar
  25. 25.
    Mohan V, Sandeep S, Deepa R, Sha B, Varghese C (2007) Epidemiology of type 2 diabetes: Indian scenario. Indian J Med Res 125(3):217–230PubMedGoogle Scholar
  26. 26.
    India State-Level Disease Burden Initiative Diabetes Collaborators (2018) The increasing burden of diabetes and variations among the states of India: the Global Burden of Disease Study 1990–2016. Lancet Glob Health 6(12):e1352–e1362Google Scholar
  27. 27.
    Klienbaum GD, Klein M (2010) Logistic regression: a self-learning text. Springer, London. CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Endocrinology & MetabolismAll India Institute of Medical SciencesNew DelhiIndia
  2. 2.Department of BiostatisticsAll India Institute of Medical SciencesNew DelhiIndia
  3. 3.Department of PediatricsAll India Institute of Medical SciencesNew DelhiIndia
  4. 4.Department of Obstetrics and GynaecologyAll India Institute of Medical SciencesNew DelhiIndia

Personalised recommendations